טוען...
Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke
Most of the contraindications to the administration of intravenous (IV) recombinant tissue plasminogen activator (rtPA) originated as exclusion criteria in major stroke trials. These were derived from expert consensus for the National Institute of Neurological Disorders and Stroke (NINDS) trial. Des...
שמור ב:
| הוצא לאור ב: | Neurohospitalist |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530420/ https://ncbi.nlm.nih.gov/pubmed/26288669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1941874415578532 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|